P S Goedegebuure - JoVE Visualize

Showing results (31-40 of 45) with videos related to

Pageof 5

Sort By:

Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1994

TCR V beta 3+ and V beta 6+ CTL recognize tumor-associated antigens related to HER2/neu expression in HLA-A2+ ovarian cancersG E Peoples, I Yoshino, C C Douville, et al.

Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|July 1, 1993

Immunomodulatory effects of interleukin-12 on human tumor-infiltrating lymphocytesJ V Andrews, D D Schoof, M M Bertagnolli, et al.

Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 5, 1999

T cells mediate treatment of six-day-old cytokine-gene-transfected mouse mammary tumorY L Matory, D M Dorfman, M Chen, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995

Adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 in patients with metastatic malignant melanoma and renal cell carcinoma: a pilot studyP S Goedegebuure, L M Douville, H Li, et al.

Cellular Immunology|August 1, 1993

CD4+ T cell clones isolated from human renal cell carcinoma possess the functional characteristics of Th2 helper cellsD D Schoof, Y Terashima, G E Peoples, et al.

International Journal of Cancer|July 27, 1999

Soluble MUC1 secreted by human epithelial cancer cells mediates immune suppression by blocking T-cell activationA K Chan, D C Lockhart, W von Bernstorff, et al.

Cellular Immunology|February 1, 1997

Simultaneous production of T helper-1-like cytokines and cytolytic activity by tumor-specific T cells in ovarian and breast cancerP S Goedegebuure, C C Douville, J M Doherty, et al.

Surgical Oncology|February 1, 1995

In vitro stimulation of ovarian tumour-associated lymphocytes with a peptide derived from HER2/neu induces cytotoxicity against autologous tumourD C Linehan, G E Peoples, D T Hess, et al.

Cancer Research|July 1, 1994

HER2/neu-derived peptides are shared antigens among human non-small cell lung cancer and ovarian cancerI Yoshino, P S Goedegebuure, G E Peoples, et al.

Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1989

Induction of lysis by T cell receptor gamma delta+/CD3+ T lymphocytes via CD2 requires triggering via the T11.1 epitope onlyP S Goedegebuure, D M Segal, E Braakman, et al.

Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:

Pageof 5

Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1994

TCR V beta 3+ and V beta 6+ CTL recognize tumor-associated antigens related to HER2/neu expression in HLA-A2+ ovarian cancersG E Peoples, I Yoshino, C C Douville, et al.

Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|July 1, 1993

Immunomodulatory effects of interleukin-12 on human tumor-infiltrating lymphocytesJ V Andrews, D D Schoof, M M Bertagnolli, et al.

Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 5, 1999

T cells mediate treatment of six-day-old cytokine-gene-transfected mouse mammary tumorY L Matory, D M Dorfman, M Chen, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995

Adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 in patients with metastatic malignant melanoma and renal cell carcinoma: a pilot studyP S Goedegebuure, L M Douville, H Li, et al.

Cellular Immunology|August 1, 1993

CD4+ T cell clones isolated from human renal cell carcinoma possess the functional characteristics of Th2 helper cellsD D Schoof, Y Terashima, G E Peoples, et al.

International Journal of Cancer|July 27, 1999

Soluble MUC1 secreted by human epithelial cancer cells mediates immune suppression by blocking T-cell activationA K Chan, D C Lockhart, W von Bernstorff, et al.

Cellular Immunology|February 1, 1997

Simultaneous production of T helper-1-like cytokines and cytolytic activity by tumor-specific T cells in ovarian and breast cancerP S Goedegebuure, C C Douville, J M Doherty, et al.

Surgical Oncology|February 1, 1995

In vitro stimulation of ovarian tumour-associated lymphocytes with a peptide derived from HER2/neu induces cytotoxicity against autologous tumourD C Linehan, G E Peoples, D T Hess, et al.

Cancer Research|July 1, 1994

HER2/neu-derived peptides are shared antigens among human non-small cell lung cancer and ovarian cancerI Yoshino, P S Goedegebuure, G E Peoples, et al.

Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1989

Induction of lysis by T cell receptor gamma delta+/CD3+ T lymphocytes via CD2 requires triggering via the T11.1 epitope onlyP S Goedegebuure, D M Segal, E Braakman, et al.

Pageof 5